Skip to main content

Advertisement

ADVERTISEMENT

Industry Insider

New Products and Industry News

Distribution agreement signed for hydroactive wound products

  Alliqua, Inc, (Langhorne, PA) signed a long-term agreement with sorbion GmbH & Co. KG to distribute the sorbion sachet S, sorbion sana, and new products with hydrokinetic fibers as primary dressings. Sorbion hydroactive wound care products will be distributed by Alliqua throughout all of the Americas.

  The sorbion sachet S and sorbion sana brands have been market leaders in the matrix metalloproteinase modulator wound dressing category in Germany and the United Kingdom for the past several years and were initially introduced into the United States’ marketplace 3 years ago. These dressings are Food and Drug Administration-cleared and are reimbursable.

  For more information, please visit www.alliqua.com.

Ankle foot orthosis introduced

  DM Systems (Evanston, IL) introduced the redesigned Heelift®AFO, an ankle foot orthosis designed to offload the heel while also providing superior foot drop support. The company, which introduced the first heel offloading boot of its kind, has established a reputation as a global leader in the prevention and treatment of heel pressure ulcers and has applied that expertise to the traditional AFO, producing a softer, gentler solution. A smooth fabric cover and forefoot strap help keep the boot in place by allowing it to move with the patient while the patient is in bed. A nonslip sole allows patients to walk short distances (preferably with assistance) —the boot does not have to be removed and reapplied each time the patient is transferred from the bed or wheelchair.

  For more information, visit www.heelift.com.

Company gets approval to sell NPWT system in Brazil

  Devon Medical (King of Prussia, PA) received medical device registration and approval from the Brazilian National Health Surveillance Agency (ANVISA) for its extriCARE® 2400 Negative Pressure Wound Therapy (NPWT) pump.

  ANVISA is Brazil’s regulatory authority for medical devices, drugs, and other products seeking to enter the country. The approval allows the company to sell its NPWT system, which comprises the extriCARE® 2400 pump and the company’s NPWT dressings, in the Brazilian market. The company received ANVISA approval for its NPWT dressings in April.

  For more information, visit www.devonmedicalproducts.com.

2013 Innovation award finalist announced

  Philadelphia Business Journal (Philadelphia, PA) and presenting sponsor UnitedHealthcare (Minnetonka, MN) announced WoundMatrix (Chadds Ford, PA) as a finalist for the 2013 Innovation Awards in the category of Best Medical Device. The awards honor innovations in healthcare that continue to reshape the medical industry in Greater Philadelphia and New Jersey.

  The company is recognized for its Mobile Wound Management technology, which provides a new level of precision and ease of use to image, measure, assess, and report wound care efficacy securely and in real time. The technology uses smartphones in an HIPAA-compliant manner to take a photo of the wound and send it in real time to the company’s back-end proprietary software, offered in the Verizon-Terremark Health Enabled Cloud. The system facilitates precise digital measurement and centralized reading of metrics. Documentation and outcome tracking reports are accessible to all treatment team members at any time for any location.

  Other finalists in the Best Medical Device category include Moss Rehab/Einstein Healthcare Network and UE LifeSciences Inc. Winners will be announced at the awards breakfast in October.

  For more information, visit www.woundmatrix.com.

Powder creates seal around catheter sites

  Biolife (Sarasota, FL) introduced StatSeal Disc to provide nurses and other medical professionals the technology to minimize catheter dressing disruptions.

  Using the same Federal Drug Administration-cleared formulation of potassium ferrate and hydrophilic polymer found in StatSeal Powder, the new product creates an instant seal to stop the flow of blood and exudates from PICC and central line insertions. The seal keeps access sites dry, intact, and protected from contamination.

  While traditional access dressings (sponges, gels, gauze) absorb blood and exudates, mandating dressing changes three times in 7 days on average, one StatSeal Disc application lasts 7 days to dramatically minimize dressing disruption.

  Currently, the powder is used in leading hospitals around the country, including six of the top 10 children’s hospitals.

  For more information, visit www.statseal.com.

Small portable pump enhances negative pressure devices

  The new Parker T2-05-IC micro diaphragm pump from the Precision Fluidics Division of Parker Hannifin Corporation (Pine Brook, NJ) is specifically designed for the needs of portable medical devices for advanced wound care. The pump provides the negative pressure required to draw down the dressing over the wound area and to maintain a constant suction for effective wound healing.

  Advanced wound management devices are getting smaller for portability and increased patient comfort. The efficiency of these devices is critical because low power consumption and minimal vacuum losses allow battery packs to last longer. This capability allows the patient to be more mobile, enabling a better quality of life.

  The pump is ideal for applications such as single patient use negative pressure wound therapy devices that require multiple dressing therapy treatments, The product is CE- and RoH- compliant, facilitating ease of integration into a medical device.

  For more information, visit www.parker.com.

This article was not subject to the Ostomy Wound Management peer-review process.

Advertisement

Advertisement

Advertisement